Morusin

Morusin: sourced facts only. name: "Herein, we employed a structure-based discovery and biological evaluation and discovered that Rottlerin (IC50 = 2.53 μM) and Morusin (IC50 = 8.29 μM) and as selective and potent USP22 inhibitors." [PMID:37769523]; target: "Herein, we employed a structure-based discovery and biological evaluation and discovered that Rottlerin (IC50 = 2.53 μM) and Morusin (IC50 = 8.29 μM) and as selective and potent USP22 inhibitors." [PMID:37769523]; developer: "College of Pharmacy, Dalian Medical University, Dalian 116044, China." [PMID:37769523]; stage: "Moreover, in an in vivo syngeneic tumor model, Rottlerin and Morusin exhibited potent antitumor activity, which was accompanied by an enhanced infiltration of T cells into the tumor tissues." [PMID:37769523]